Introduction
The Myc family of oncoproteins is considered to play a central role in the control of cell proliferation, dierentiation and apoptosis. The expression of the cmyc gene is tightly controlled at the transcriptional and post-transcriptional level and usually closely mirrors the proliferative state of the cell. The c-myc gene is transcribed at a low level in resting cells but is activated as an early response gene after mitogenic stimulation by a variety of growth factors. Furthermore, the expression of c-myc is down-regulated in many cell systems as cells enter a dierentiation pathway, thereby exiting the cell cycle. Oncogenic events such as translocations, amplifications, retroviral transductions or insertions and point mutations which aect regulatory regions of the c-myc gene result in deregulated expression and may lead to uncontrolled proliferation, block of dierentiation, induction of apoptosis and inability to exit the cell cycle (for review see Marcu et al., 1992; Henriksson and LuÈ scher, 1996) .
Myc proteins belong to the basic region/helix ± loop ± helix/leucine zipper (bHLHZip) family of transcription factors and form heterodimers with the bHLHZip protein Max (Blackwood and Eisenman, 1991; Blackwood et al., 1992) . This interaction is mediated by the HLHZip domains of the two proteins and enables the dimer to speci®cally recognise the DNA sequence CACGTG or related DNA motifs referred to as Myc E-boxes (Blackwell et al., 1990; . In contrast to Max, c-Myc contains a transactivation domain at its Nterminus and the Myc : Max complex is thereby capable of activating transcription from arti®cial promoters containing CACGTG-motifs Kretzner et al., 1992; Amin et al., 1993; Gu et al., 1993) . Since c-Myc can not homodimerize it is dependent on Max to function as a transcription factor. In addition, the interaction with Max is crucial for the biological activities of c-Myc including stimulation of growth, block of dierentiation and induction of apoptosis (Prendergast et al., 1992; Amati et al., 1993a,b) and it is therefore believed that c-Myc : Max heterodimers modulate these functions by directly regulating speci®c target genes (for review see Henriksson and LuÈ scher, 1996) .
In addition to c-Myc, Max binds at least ®ve other bHLHZip proteins, Mad1, Mxi1 (Mad2), Mad3 and Mad4, collectively referred to as the Mad family Zervos et al., 1993; Hurlin et al., 1995a) and Mnt/Rox (Hurlin et al., 1997; Meroni et al., 1997) . These proteins bind as heterodimers with Max to the same Myc E-box DNA recognition sequences as Myc : Max but, in contrast to c-Myc, repress transcription from promoters containing these motifs. Furthermore, transfection of mad genes inhibit the ability of c-Myc to transform primary ®broblasts together with activated Ras in cotransformation assays (Lahoz et al., 1994; Cerni et al., 1995; Chin et al., 1995; Hurlin et al., 1995a; Koskinen et al., 1995; VaÈ strik et al., 1995) and arrest growth of several cell types in the G1 phase of the cell cycle Roussel et al., 1996; A Menkel, J Mertsching and BL, unpublished data) . These results thus suggest that the Mad proteins act as antagonists to Myc. The described anti-Myc-activities of Mad and Mnt/Rox seem to be dependent on a conserved domain in these proteins which binds mammalian homologues of the yeast repressor protein Sin3 Schreiber-Agus et al., 1995) . The expression of mad1 and mxi1 is induced during in vitro dierentiation of myeloid cell lines Zervos et al., 1993; Larsson et al., 1994) and keratinocytes (Hurlin et al., 1995b) resulting in a shift in the ratio of Maxcontaining heterodimers from predominantly cMyc : Max in proliferating, undierentiated cells to Mad : Max in dierentiated, non-proliferating cells Hurlin et al., 1995b) . Studies of neuronal and epithelial tissues during embryonic development or in adults suggested that the mad family genes, in contrast to the myc family genes, are preferentially expressed in resting, dierentiated cells (Hurlin et al., 1995a; VaÈ strik et al., 1995) . These observations have lead to the hypothesis that Max and the Myc and Mad family proteins form a network which may function as a molecular switch during growth and dierentiation.
These data may suggest that the main regulation of the Myc/Max/Mad network lies in the signal-mediated control of the expression of myc and mad family genes, whereas the expression of max seems to be less variable. It is still an open question whether posttranslational regulation of the members of the network also occurs in response to external signals. Such a regulation could operate for instance by regulating the interaction of Max with its partners, the DNA-binding activity, the transactivating/transrepressing functions of the complexes or the turnover of the components.
Studies on the DNA-binding activity of endogenous Myc, Max and Mad proteins from cell extracts have so far been hampered by methodological problems. It is very dicult to detect DNA-binding complexes of these proteins using conventional DNA-binding assays such as electrophoretic mobility shift assays (EMSA) unless they are highly overexpressed, primarily due to their low abundance and the presence of other predominating proteins binding to the same DNA recognition sequence Cerni et al., 1995; our unpublished results) . In an attempt to address the important issue of possible post-translational regulation of the Myc network we have developed a solid phase DNA-binding assay based on partial puri®cation of native protein complexes using immunological methods. We have applied this assay to study the DNA-binding activity of Myc, Max and Mad1 during induced dierentiation of U-937 monoblasts (Nilsson et al., 1980) and F9 teratocarcinoma cells (Strickland and Mahdavi, 1978) .
Results

Development of a solid phase DNA-binding assay for Myc and Max immunocomplexes
Initial attempts to study the DNA-binding activity of Myc : Max heterodimers from nuclear or total U-937 cell extracts by EMSA were unsuccessful (data not shown). In order to circumvent these problems we developed an alternative strategy as outlined in Figure  1 . In short c-Myc : Max complexes were immunoprecipitated from low stringency cell lysates and, while bound to protein A-Sepharose beads, were analysed for DNA-binding. To con®rm that our lysis conditions and the antisera used preserved the interation between Myc and Max, we lysed 35 S-labelled U-937 myc-6 ( Figure 2a ) and U-937-GTB (Figure 2b ) cells in high stringency AB-buer or low stringency L-buer. The lysates were immunoprecipitated with pan-Myc or Max antisera and analysed on SDS ± PAGE. Figure 2a and b show that Myc was coimmunoprecipitated with Max antiserum and vice versa Max with pan-Myc antiserum under low but not high stringency conditions. U-937-myc-6 cells contain in addition to p62 c-Myc also p57 v-Myc (Larrson et al., 1988) . Since Myc may be dicult to detect in anti-Max immunoprecipitates due to the high background, we also washed the pellet in AB-buer to release Myc and then reimmunoprecipitated with pan-Myc antiserum. As shown in Figure 2a the anti-Max immunoprecipitates clearly contained cand v-Myc.
We then used the same mild lysis conditions and antisera to perform the solid phase DNA-binding assay ( Figure 1 ) using unlabelled U-937-myc-6, BK3A and Manca cell lysates (Figure 3a In order to optimise the conditions for the DNAbinding assay further we tested dierent concentrations of salmon sperm DNA as a non-speci®c competitor and the CMD concentration. From these experiments we found that 1 ± 2.5 ng of labelled oligonucleotide with 100 ng of salmon sperm DNA per reaction was optimal (data not shown). In addition the amount of antibody was titrated to ensure sucient excess of antibody (exempli®ed in Figure 3c ). Also the amount of cell lysate was titrated to determine the lower detection limits (Figure 3d ). Max DNA-binding activity could readily be detected using as few as 250 000 cells. Finally, we tested dierent buer conditions for lysis of the cells ( Figure  3e ). 0.5% SDS abolished the binding of both anti-Max and anti-Myc immunocomplexes as expected. Addition of 0.5% desoxycholate (DOC) only partially inhibited the binding. This is consistent with the relative ineciency of DOC to disrupt c-Myc :Max complexes in U-937 cell extracts (data not shown). Other whole cell extraction procedures such as Frackelton-and Tris lysisbuer (see Materials and methods) were comparable to the L-buer which we have used most frequently.
To summarize the methodological part of the work we have shown that the described technique is a sensitive assay for measuring speci®c DNA-binding of Myc-and Max-containing complexes. The assay works well for several dierent antisera as well as for extracts from dierent types of cells, is saturable regarding oligonucleotide and antisera concentrations and is linear regarding amounts of cell extracts.
DNA-binding activity of Myc and Max during induced dierentiation of U-937 cells
Our conclusion from the data shown above was that the solid phase DNA-binding assay could be a useful method for studying the potential regulation of Myc and Max DNA-binding activities during a dynamic process such as cell dierentiation. We ®rst employed the U-937 dierentiation model (Nilsson et al., 1980) . U-937-1 cells were induced by a phorbol ester (TPA), vitamin D 3 (VitD 3 ), retinoic acid (RA) or interferon (IFN)-g for 3 days. Growth and dierentiation were studied by cell counting and FACS analysis of the dierentiation marker CD11c. In agreement with our previous report (Larsson et al., 1994) . TPA, RA and VitD 3 , and to a lesser extent IFN-g, inhibited cell growth and induced the cell surface expression of CD11c (Table 1 ). The somewhat less ecient overall response to VitD 3 as compared to TPA and RA by 3 days of induction is due to the somewhat slower kinetics of VitD 3 -induced dierentiation (data not shown). In addition we quantitated the expression of c-myc and max mRNA by Northern blot followed by imager analysis and normalised it to the levels of actin mRNA (Table 1) . Whereas c-myc mRNA was downregulated to various degrees, which correlated well with the proliferative activity and inversely with the dierentiation of the cells, little change in max expression was observed (Table 1) .
Total cell extracts prepared from the untreated and the induced cells were immunoprecipitated with Myc and Max antisera and analysed for speci®c DNAbinding activity using 32 P-labelled CMD oligonucleotide as above. Table 1 shows that the DNA-binding activity of anti-Myc immunocomplexes was substantially reduced after TPA, RA and VitD 3 treatment, but was less aected by IFN-g treatment. This corresponded very well to the observed reduction in c-myc S-methionine and lysed in high stringency AB-buer or low stringency L-buer as indicated in the ®gure. The lysates were immunoprecipitated with R2 Myc, 3811E Max or normal rabbit antiserum, collected on protein A Sepharose and washed under high or low stringency conditions followed by SDS ± PAGE analysis as described in Materials and methods. Coimmunoprecipitated c-and v-Myc proteins were visualized in (a) by washing the low stringency antiMax immunoprecipitate under high stringency conditions followed by immunoprecipitation of the supernatant with Myc antiserum. In (b) coimmunoprecipitated Max and c-Myc from labelled U-937-GTB lysates are visible directly in anti-Myc and anti-Max immunoprecipitates, respectively mRNA expression. The DNA-binding activity of antiMax complexes showed a dierent pattern. A small reduction was observed after TPA treatment, whereas the DNA-binding slightly increased after VitD 3 , RA and IFN-g treatment.
We next studied DNA binding activities during the early phase of TPA-induced dierentiation. In both control cells (U-937-GTB) and in v-Myc-expressing cells (U-937-myc-6) Myc-dependent DNA-binding was rapidly downregulated (Figure 4a ). This was occurring faster than the downregulation of c-Myc expression measured both by metabolic labelling and Western blotting ( Figure 4b and data not shown) and despite the continuous expression of v-Myc in the U-937-myc-6 cells. This early phase of TPA-induction in U-937-myc-6 as well as in U-937-GTB cells coincides with growth inhibition and onset of dierentiation (Larsson et al., 1988) . To investigate whether the rapid decline in Myc DNA-binding could be due to reduced c-or vMyc : Max dimerization, the portion of Myc coimmunoprecipitated with Max was compared with the total amount of synthesized Myc (Figure 4b, right panel) . U-937-1 cells (0.1610 6 per ml) were induced to dierentiate by the indicated agents for 3 days after which the cells were counted and the expression of the monocytic dierentiation marker CD11c was measured by FACS analysis. For Northern blot analysis of c-myc and max mRNA expression, 15 mg of total RNA isolated from untreated and dierentiated cells was separated on a formaldehyde-containing agarose gel, blotted to nitrocellulose and hybridized to 32 P-labelled human c-myc and max probes as described previously (Larsson et al., 1994) . S-methionine and unlabelled U-937-myc-6 cells (right panel) were lysed in AB-buer and immunoprecipitated with C17 Max antiserum followed by SDS ± PAGE. The unlabelled proteins (right panel) were then subjected to Western blot analysis using C17 antiserum Equivalent ratios of total Myc versus Myc coimmunoprecipitated with Max were observed for each time point suggesting that TPA-treatment results in a posttranslational inhibition of Myc-speci®c DNAbinding. By contrast little dierence in the DNAbinding of Max complexes and in the synthesis rate and steady state level of Max could be observed (Figure 4a,c) .
DNA-binding activity of Mad1 during induced dierentiation of myeloid cells
We and others have previously shown that mad1 expression is induced during in vitro dierentiation of U-937 and other myeloid cells Zervos et al., 1993; Larsson et al., 1994) . The solid phase DNA-binding assay was therefore employed to study the DNA-binding activity of Mad1 during this process. We ®rst determined whether interactions between Mad1 and Max could be detected in U-937 cells. Lysates from untreated and TPA treated 35 S-labelled U-397-1 cells were immunoprecipitated under high and low stringency conditions using C-19 Mad1 and C-17 max antisera, respectively. The pellet from the low stringency Max immunoprecipitation was subjected to a high stringency wash in order to release bound Mad1 and then reprecipitated with Mad1 antiserum. The synthesis of Mad1 increased after TPA treatment as expected and was coimmunoprecipitated with Max (Figure 5a ). Small amounts of Lysates of unstimulated and TPA stimulated U-937-1 cells were then analysed for Mad1 DNA-binding activity using two dierent Mad1 antisera, C19 and 266-4. As shown in Figure 5c DNA-binding activity of both C19 and 266-4 immunocomplexes was detected. The activity increased after TPA treatment, thus correlating to the increased synthesis of Mad1 and the increased amount of Mad1 in complex with Max after TPA stimulation. Only background binding was observed using the 266-0 preimmune serum.
Using the 266-4 Mad1 antiserum we analysed Mad1 DNA-binding activity 48 h after TPA-induced monocytic dierentiation in U-937-1, HL-60 and ML-1 myeloid cells. Increased binding of Mad1-containing immunocomplexes to the CMD oligonucleotide was observed in all three cell lines after dierentiation (Figure 5d ). Also mad1 mRNA expression was induced to similar levels in the three cell lines as reported previously (data not shown; see Larsson et al., 1994) .
DNA-binding activity of Myc and Max during induced dierentiation of F9 teratocarcinoma cells
To study the DNA-binding activity of Myc and Max in another cell system we chose the murine F9 embryonic teratocarcinoma dierentiation model (Strickland and Mahdavi, 1978) . F9 cells were induced to dierentiate towards parietal endoderm by RA+dbcAMP stimulation. The cells ceased to proliferate 2 days after treatment (data not shown) and morphological changes indicative of parietal endoderm differentiation gradually developed during the following days ( Figure  6a A ± D) . The expression of c-myc and max mRNA was examined in Northern blot analysis (Figure 6b ). The level of c-myc mRNA gradually declined and reached a minimum after 2 days in agreement with previous reports (Dony et al., 1985) . Little variation in the expression of max mRNA was observed. Western blot analysis of the Max proteins, however, revealed a gradual decline in the steady state level of p21 and in particular p22 Max during the course of dierentiation (Figure 6c ) thus demonstrating a post-transcriptional regulation of Max expression in these cells. We could not detect mad1 mRNA expression in these cells at any time point (data not shown).
Cell extracts were prepared from undierentiated and dierentiating cells and the DNA-binding activity of c-Myc and Max was determined using Myc and Max antisera. The DNA-binding activity of anti-Myc immunocomplexes gradually declined during the course of dierentiation with kinetics which closely resembled the reduction in c-myc mRNA levels (Figure 6d) . The increased c-Myc DNA-binding at day 7 is probably not signi®cant since the background binding was also increased. A slight gradual reduction Max DNAbinding activity to approximately 60% of untreated cells was also observed during the ®rst 3 days of dierentiation (Figure 6e ). The magnitude of this reduction resembled that of the reduced total amount 
Discussion
Regulation of speci®c DNA-binding activity has been described for several transcription factors such as cJun, c-Myb, SRF, myogenin and Oct1 (for review see Hunter and Karin, 1992) . This regulation can be accomplished by at least three dierent mechanisms. First, DNA-binding of transcription factors is often dependent on homo-or heterodimerization. Therefore, modi®cations which aect the interaction between the monomers or the availability of a dimerization partner as determined by its expression or the presence of competing proteins will in¯uence the DNA-binding capacity of a given factor. Secondly, positively or negatively acting cofactors interacting with the dimer may in¯uence its DNA-binding activity. Finally, modi®cations such as phosphorylation/dephosphorylation may directly aect the DNA-binding of a transcription factor.
All three mechanisms have been suggested to be in operation for the regulation of the Myc/Max/Mad network. Studies of Myc, Max and Mad in dierent cellular systems suggest that one major level of regulation of this network is the control of expression of the myc-and mad family genes, which determines the predominating composition of Max-containing heterodimers in cells Zervos et al., 1993; Larsson et al., 1994; Hurlin et al., 1995a,b; VaÈ strik et al., 1995) . Recent data indicate that also other Max-interacting proteins take part in this competition (Hurlin et al., 1997; Meroni et al., 1997) . There are also reports suggesting that c-Myc can interact with other transcription factors such as YY1 (Shrivastava et al., 1993 ; M Austen and B LuÈ scher, unpublished observations), AP-2 (Gaubatz et al., 1995) and TFII-I (Roy et al., 1993) which potentially could in¯uence its DNA-binding properties. Finally, there is evidence showing that the DNA-binding activity of both Max : Max homodimers and c-Myc : Max heterodimers can be modulated by CK2 phosphorylation (Berberich and Cole, 1992; Bousset et al., 1993) . Table 1 using 88-6 Myc and 91-6 Max antisera and 1 ng of labelled CMD oligonucleotide. The speci®city of the DNA-binding was determined by using preimmune sera (88-0 and 91-0) and by competing with a 50-fold molar excess of unlabelled CMD and mutated CMM oligonucleotides as indicated 1995), in particular in response to external signals. These previous studies have been performed by EMSA using cells which highly overexpress the studied proteins. The EMSA technique has, however, not been very successful to study DNA-binding of Myc, Max and Mad in cells which express more physiological levels of the proteins. The main problem has been the often low abundance of the proteins, the diculty to extract the proteins in standard Dignam extracts and the high background of other unrelated proteins binding the CACGTG motif. In order to overcome these limitations we now report the development of an alternative DNA-binding assay. This technique is based on a solid phase assay using partially puri®ed native Myc/Max/Mad complexes isolated by immunological methods. A similar approach has been used to study DNA-binding of the SV40 large T antigen (McKay, 1981) . In this study cell extracts of infected cells were incubated with labelled DNA probes after which large T antigen/DNA complexes were immunoprecipitated and the speci®c DNA-binding was measured. This assay system has also been applied to Myc : Max complexes derived either from in vitro transcriptions/ translations in rabbit reticulocyte lysate or from HeLa cell extracts . This work suggested that principally DNA-binding of Myc : Max and Max : Max complexes can be measured when bound to antibodies. Our results now show that the solid phase DNAbinding assay for immunocomplexes of Myc/Max/Mad family proteins is very sensitive and can be used to study the DNA-binding activity of non-overexpressed, endogenous Myc, Max and Mad1 complexes in as few as 250 000 cells, which is an advantage when the amounts of cells are limiting. Since the major part of Myc E-box binding activity in whole cell extracts is due to proteins other than those of the Myc/Max/Mad family, the assay described here avoids competition for DNA by such proteins. We have also shown that the binding of the immunocomplexes to the CACGTGcontaining oligonucleotide is very speci®c. It is detectable with a number of dierent Myc, Max and Mad1 antisera, whereas preimmune or normal rabbit sera give only background binding. The binding is also abolished by pre-incubating the antisera with peptide or by competing with excess unlabelled oligonucleotide but not by oligonucleotides containing mutated versions of the Myc/Max binding site (Figure 3 and data not shown). The major drawback with the technique is that it only gives information on the total binding of Myc, Max or Mad1 containing complexes. Although we have shown that anti-Myc and anti-Mad1 immunocomplexes contain Max and vice versa, it is not possible to distinguish whether there are dierent types of complexes formed or whether their composition varies. It may be possible to solve these problems by competing away the antibodies by peptide followed by analysis of the complexes by EMSA. We are currently working on these modifications of the technique. Another concern is the possibility that certain antibodies may change the conformation of the complexes or disrupt binding of potential interacting factors, thereby aecting the DNA-binding properties of the proteins. Such eects can be analysed using Cos-7 cell overexpressed proteins in combination with gel shifts (A Sommer, K Bousset and BL, unpublished data) . This obviously has to be studied further.
Despite these disadvantages we believe that this technique can give valuable information on the DNAbinding activity of the proteins of the Myc/Max/Mad network under various conditions. We have applied this assay to studies of Myc, Max and Mad1 DNA-binding activity during induced dierentiation using two dierent model systems; monocytic dierentiation of U-937 monoblasts (Table 1, Figures 4 and 5) (Nilsson et al., 1980) and dierentiation of F9 embryonic teratocarcinoma cells towards parietal endoderm (Figure 6 ) (Strickland and Mahdavi, 1978) . Our results show that changes in DNA-binding activity of these complexes indeed can be observed in both systems during dierentiation. The DNA-binding of c-Myc-containing complexes is gradually reduced after stimulation in U-937 and F9 cells. In general, this reduction seems to correlate well with the level of expression of c-myc mRNA and protein. Also the increased Mad1 DNAbinding observed after TPA stimulation of U-937, HL-60 and ML-1 cells correlates with the increased mad1 mRNA and protein expression and the increased formation of Mad1 : Max heterodimers.
However we have found at least two situations in which the protein expression did not strictly correlate with the measured DNA-binding capacity. First, in U937 cells c-Myc levels are initially slightly enhanced early during dierentiation whereas consistently DNAbinding was rapidly reduced. This was also observed in U-937-myc-6 cells which continuously express v-Myc. Together these ®ndings suggest that c-Myc : Max DNA-binding is regulated by additional means than expression levels. This seems not to be due to reduced Myc : Max dimer formation since the ratio of total Myc and Myc in complex with Max was constant during dierentiation but rather an eect on the speci®c activity of DNA-binding. Phosphorylation of Max at the N-terminal CK2 sites eects DNA-binding (Berberich and Cole, 1992; Bousset et al., 1993) and, in addition, c-Myc is also phosphorylated by CK2 near the basic region (LuÈ scher et al., 1989) . Thus altered stoichiometry of phosphorylation at these sites could aect DNA-binding. Experiments to address this are in progress. Another possibility is that the DNA-binding activity of Myc : Max is modulated by other interacting proteins which are regulated by TPA. Second, the steady state levels of Max proteins decline gradually during F9 dierentiation, still the DNA-binding activity of Max complexes, although reduced, stabilises at a quite high level. At present we do not know the composition of these complexes. The Max DNAbinding activity observed in all instances will represent the sum of the contribution of Max : Max homodimers and all types of Max-containing heterodimers in the cell that can be immunoprecipitated with the Max antiserum used. Since at present we only have access to antiserum towards c-Myc and Mad1 (which is not expressed in F9) we have not been able to analyse the contribution of other known Max-interacting proteins. Possible interpretations of the F9 Max DNA-binding data is that new types of Max heterodimers with strong anity to DNA or Max : Max homodimers with increased anity form during dierentiation, which could compensate for the reduced total level of Max in the cell.
The reduced total level of Max proteins, but not max mRNA, points at a post-transcriptional regulation of Max expression not previously documented. It also challenges the generally held view that Max levels are fairly constant in cells. Changes in max expression, however, have been observed during dierentiation also in other cell types. Induced erythroid differentiation of MEL and K-652 cells (Dunn et al., 1994; Delgado et al., 1995) and TPA-induced monocytic dierentiation of HL-60 and to a lesser extent ML-1 and U-937 myeloid cells are accompanied by a reduced expression of max (Larsson et al., 1994) . The ratio between total Max and Myc DNA-binding activity is much higher (10 : 1) in F9 cells compared to other cell types we have studied (2-3 : 1). This may indicate that early embryonic cells express a very high level of Max which is later down-modulated during the development.
Our data on the DNA-binding activity of Myc, Max and Mad1 so far seem to con®rm the view that the main regulation of the network is at the level of expression of its components, since most of the observed changes in DNA-binding correlate with dierences in gene expression. However, our studies of early kinetics of TPA-induced dierentiation of U-937 cells as well as of late events during F9 dierentiation suggest that post-translational regulation of DNA-binding may also occur. Additional studies will be required to elucidate the relevant mechanisms.
Materials and methods
Cell culture and dierentiation assays
The cells were cultured in RPMI-1640 medium (U-937, HL-60 and ML-1) or DMEM medium (F9 and Manca) supplemented with 10% fetal calf serum and antibiotics BK3A cells were grown in DMEM supplemented with 5% calf serum, 1% chicken serum and 10% tryptone broth. U-937 (Nilsson et al., 1980) , HL-60 (Collins et al., 1977) and ML-1 (Han and Minowada, 1980) are human myeloid cell lines, Manca (Nishikori et al., 1984) is a human Burkitt's lymphoma cell line, BK3A (Hihara et al., 1974 ) is a chicken bursal lymphoma cell line and F9 (Strickland and Mahdavi, 1978 ) is a murine embryonic teratocarcinoma cell line. The U-937 clones, U-937-myc-6, containing the OK10 v-myc gene, the parental clone U-937-GTB and the U-937-1 clone have been described previously (Larsson et al., 1988 (Larsson et al., , 1994 . For in vitro dierentiation of U-937, HL-60 and ML-1, exponentially growing cells (10 5 /ml) were induced in medium containing 1.6610 78 M TPA (Sigma, St Louis, MO), 10 77 M VitD 3 (a generous gift from HofmannLa Roche), 10 76 M RA (Sigma) or 100 U/ml IFN-g (generously provided by Dr GR Adolf, Ernst-Boehringer Institute, Vienna, Austria). F9 cells were induced to dierentiate in medium containing 10 76 M RA and 1 mM dbcAMP. Immuno¯uorescence studies of CD11c, the asubunit of the gp105.95 adhesion molecule which is a marker of monocytic dierentiation (Miller et al., 1986) , were performed using the mAb LeuM5 (Becton & Dickinson, Mountain View, CA) as described previously (O È berg et al., 1991) .
Immunoprecipitation and Western blot analysis
5610
6 cells were labelled for 40 min in 1 ml of methioninefree RPMI-1640 containing 0.15 mCi of 35 S-methionine.
For high stringency immunoprecipitations cells were lysed in AB buer (20 mM Tris pH 7.4, 50 mM NaCl, 1 mM EDTA, 0.5% NP-40, 0.5% sodium desoxycholate, 0.5% SDS, 0.5% aprotinin, 0.5 mM phenylmethylsulphonyl uoride (PMSF)), sonicated, cleared by centrifugation and immunoprecipitated with antibodies as described (LuÈ scher and Eisenman, 1988 ). An equal number of TCA-precipitable counts were used for each sample. The immunocomplexes were collected with protein A-Sepharose CL4B (Sigma) and washed twice with RIPA buer (10 mM Tris, pH 7.4, 150 mM NaCl, 1% NP-40, 1% desoxycholate, 0.1% SDS, 0.5% aprotinin), once with high salt buer (2 M NaCl, 10 mM NaCl pH 7.4, 1% NP-40, 0.5% desoxycholate) and ®nally with RIPA (LuÈ scher and Eisenman, 1988) . For low stringency immunoprecipitations the cells were suspended in L buer (PBS, 1% NP-40, 0.5 mM PMSF, 0.5% aprotinin, 10 mM NaF, 50 mM b-glycerophosphate, 0.5 mg/ml pepstatin, 100 mM orthovanadate, 0.5 mM benzamidine, 2.5 mg/ml leupeptin, 1 mM DTT), vortexed brie¯y, lysed for 10 min on ice, centrifuged and immunoprecipitated . The beads were then washed four times in L buer. The SDS ± PAGE samples were analysed on 10 ± 15% polyacrylamide gels under reducing conditions.
For Western blot analysis unlabelled cells were lysed under low stringency conditions. The protein concentration was measured using a Biorad assay (Biorad Laboratories, Richmond, CA) and an equal amount of proteins was immunoprecipitated and washed as above. The immunocomplexes were resolved on a polyacrylamide gel and electroblotted (Biorad) to a nitrocellulose ®lter. The ®lter was incubated with the antibody in blocking buer (PBS, 0.5% NP-40, 5% milk powder). After washing (PBS, 0.5% desoxycholate, 0.5% NP-40) the blot was developed by enhanced chemiluminescence (Amersham, Buckinghamshire, UK) using horseradish peroxidase (HRP) conjugated antirabbit Ig (Amersham).
Solid phase DNA-binding assays
Cells were lysed under low stringency conditions in L-, Frackelton (10 mM Tris pH 7.05, 50 mM NaCl, 30 mM NaPPi, 50 mM NaF, 5 mM ZnCl 2 , 100 mM Na 3 VO 4 , 1% Triton X-100, 1 mM PMSF) or Tris (0.1 M Tris pH 8.0, 0.15 M NaCl, 5 mM EDTA, 1% NP-40, 1 mM PMSF) lysis buer. Equal amounts of protein were incubated on ice for 2 h with the antibody. The immunocomplexes were collected by protein A-Sepharose beads, washed three times in lysis buer and once in gelshift buer (20 mM HEPES pH 7.3, 50 mM KCl, 3 mM MgCl 2 , 1 mM EDTA, 8% glycerol, 0.1% aprotinin, 1 mM b-mercaptoethanol) at 48C. The samples were then incubated with 1 ng of 32 P-labelled oligonucleotide in 30 ml of gelshift buer containing 100 ng of salmon sperm DNA for 25 min at 258C. The immunocomplexes were then washed three times in gel shift buer at 48C and the amount of bound oligonucleotide was measured in a scintillation counter.
The oligonucleotides used were CMD (which contains an optimal Myc/Max binding site, underlined), CMM and CMM-1 (which contain mutated Myc/Max binding sites) or E-pal (which contains an E-box sequence from the promoter of the E-cadherin gene) obtained from W Birchmeier.
CMD
5'-TCAGACCACGTGGTCGGG CMM 5'-TCAGACCAGCTGGTCGGG CMM-1 5'-TCAGACACCGTGGTCGGG E-pal 5'-GATCCGGCTGCCACCTGCAGGTGCGTCCCG The oligonucleotides were end-labelled by T4 polynucleotide kinase and then puri®ed on a 8% polyacrylamide gel.
